Form 13-F position report

ESSA PHARMA INC

Reported by Shay Capital LLC

EPIX CUSIP 29668H708 Manager CIK 0001723643

First reported at 24,631 shares this quarter.

New
% of reported 13F value < 0.01% This manager · Q1 2025
Shares 24,631 Quarter-end amount reported
Reported value $38,917 Fair value at quarter end
Consecutive quarters held 1 Through Q1 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-03-31 38917
2025-06-30 41392
2025-09-30 102478
2025-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for ESSA PHARMA INC held by Shay Capital LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2025 Reduced 0 -536,533 (-100.0%) 0 $0 2026-02-17
Q3 2025 Added 536,533 +512,185 (2103.6%) < 0.01% $102,478 2025-11-14
Q2 2025 Reduced 24,348 -283 (-1.1%) < 0.01% $41,392 2025-08-14
Q1 2025 New 24,631 +24,631 (0.0%) < 0.01% $38,917 2025-05-15

Who else reported the position

49 managers reported ESSA PHARMA INC for Q1 2025.

Managers reporting ESSA PHARMA INC in Q1 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BVF INC IL Unchanged 8,748,629 0 0.56% $13,822,834 28 qtrs
TANG CAPITAL MANAGEMENT LLC Unchanged 4,300,000 0 0.38% $6,794,000 2 qtrs
MORGAN STANLEY Added 4,299,768 +103,899 < 0.01% $6,793,633 22 qtrs
BML Capital Management LLC Unchanged 4,221,546 0 5.4% $6,670,043 2 qtrs
Soleus Capital Management L P Unchanged 2,262,026 0 0.26% $3,574,001 22 qtrs
Opaleye Management Inc Unchanged 2,209,998 0 0.78% $3,491,797 2 qtrs
PFIZER INC Unchanged 1,675,000 0 0.53% $2,646,500 2 qtrs
Altium Capital Management LP Reduced 1,050,369 -377,631 4.0% $1,659,583 2 qtrs
Bank of America Corporation Reduced 698,268 -114,042 < 0.01% $1,103,264 23 qtrs
Aldebaran Capital LLC Added 569,294 +171,771 0.85% $899,485 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2025
Filed
May 15, 2025
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
24,631
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.